DANIEL LEE: Open Payments
NPI 1043241672 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$698 in 38 payments from 12 companies in 2025. Trend: 2023 $466 · 2024 $479 · 2025 $698
Food & beverage: $698
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $183 |
| Novo Nordisk Inc | 5 | $90 |
| Lilly USA, LLC | 5 | $78 |
| Sumitomo Pharma America, Inc. | 4 | $73 |
| GlaxoSmithKline, LLC. | 4 | $69 |
| PFIZER INC. | 3 | $65 |
| ABBVIE INC. | 2 | $42 |
| Exact Sciences Corporation | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $15 |
Products named: BREZTRI, GEMTESA, BEXSERO, KISUNLA, AIRSUPRA, Ozempic, NURTEC ODT, Cologuard Collection Kit.
Industry payments across OH — which companies pay providers there.
